Pegasus expands Pharma team with senior hires
March 11, 2019 |
Five new recruits support further growth of the Pharma & Life Sciences team
From top left: Ed Sexton, Holly Willmott, Adam Pett. From bottom left: Riana Horner, Jen Lewis
Following continued portfolio growth throughout 2018, Pegasus, an Ashfield Company, part of UDG Healthcare plc, has bolstered its Pharma & Life Sciences practice with the appointment of five new team members in recent weeks.
The new recruits bring additional sector expertise and further strengthen the agency’s integrated communications offering.
James Osborn, Director, Pharma & Life Sciences at Pegasus, said: “The expansion of our team follows a year of significant, consistent growth. I’m delighted to welcome our newest recruits and look forward to working alongside them. Their experience and spirit will enable us to create even more inspirational campaigns that help improve people’s lives.”
The hires include Adam Pett, Senior Account Director, who brings 20 years of marketing communications experience to Pegasus. He has delivered brand and advertising campaigns for a range of clients including Roche, UK Stem Cell Foundation and Department of Health, as well as BBC Worldwide, Procter & Gamble and Amazon.
Jen Lewis joins Pegasus as an Account Director from precision oncology company Agendia, where she was Director of Strategic Marketing and Communications EMEA. Jen has over 10 years’ experience in agency and in-house medical communications.
Account Director, Ed Sexton, previously led media relations for the UK BioIndustry Association, whose award-winning Brexit campaign represented more than 330 life sciences companies in the UK. A journalist by training, Ed has a strong track record in corporate and policy-based communications.
Additionally, Riana Horner joins as Account Manager with cross-sector social and digital marketing expertise from her previous role at Space Digital (Australia). Senior Account Executive, Holly Wilmott, arrives from health agency Creative Connection.
Pegasus recently won silver at the PM Society Awards for its innovative ‘reverse poem’ that marked twenty years of progress in HIV treatment. The recognition follows the agency winning the Charity Challenge Award at the 2018 PharmaTimes Communications Team of the Year 2018 and being ‘Highly Commended’ for Consultancy of the Year at last year’s Communique Awards.
Pegasus’ recruitment drive in Pharma & Life Sciences continues this month, with newly created roles including Senior Account Manager. To learn more about life at Pegasus and career opportunities in the Pharma & Life Sciences team visit: http://thisispegasus.co.uk/vacancies/ or email careers@thisispegasus.co.uk
ENDS
For more information about Pegasus, supporting imagery, or to arrange an interview, please contact Kate Gerrard on +44(0) 1273 712 102 / kate.gerrard@thisispegasus.co.uk
Notes to editors
About Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching campaigns across industries and channels in a health first, sector second approach. Our 140 specialists span earned and owned channels, technologies, and audiences ranging from consumers to healthcare professionals. And, as part of Ashfield Healthcare Communications, we have a global footprint across 32 countries and every conceivable therapy and service area. Being plugged in to this wider network means we’re able to provide end-to-end solutions to healthcare organisations across the world. For more information, go to www.thisispegasus.co.uk
About Ashfield Healthcare Communications
Ashfield Healthcare Communications, part of UDG Healthcare plc, provides global solutions for clients, adding value through unique insights and tailored, scientifically rigorous, multichannel, healthcare communications offerings. Its mission is to improve lives by helping healthcare professionals and patients get the medicines, knowledge, and support they need. Ashfield Healthcare Communications’ multichannel and specialist agencies include ACUMED, Ashfield Digital & Creative, Ashfield Healthcare Communications K.K., BlueMomentum, Cambridge BioMarketing, CircleScience, Clinical Bridges, CodonMedical, CreateNYC, FireKite, Galliard, Gardiner-Caldwell Communications, GeoMed, iMed Comms, Infusion, InterPhase Consult, Nyxeon, Pegasus, Physicians World Europe, QXV Comms, Scientific Connexions, Seren Communications, StemScientific, Watermeadow Medical and Zoetic Science. For more information, go to www.ashfieldhealthcarecommunications.com
This content was provided by Inizio
Company Details
Latest Content from Inizio
From activity to impact: 5 takeaways from MAPS Americas 2026
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now...
Inizio launches Intelligent Congress: Turning medical event investment into measurable impact
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize...
Inizio Unveils Next-Generation Hub Services at Asembia 2026, Setting a New Standard in Patient Access
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the...
Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
How did multifaceted support from across Inizio help a biotech firm prepare for launch?
Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.
Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency
Explore Inizio Medical's key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.
Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...
AI in practice: 4 real-world use cases in health and life sciences
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...
How will AI change field training?
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...